About this episode
TWiV discusses whether or not Omicron should be designated a new serotype of SARS-CoV-2, and the finding that amino acid changes that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway.
Hosts: Vincent Racaniello, Alan Dove, and Rich Condit
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- ABRCMS ePoster Spring Symposium for Emerging Scientists
- ASV Annual Meeting Registration (ASV)
- Microbiology & Immunology at LSU Health
- Is Omicron a new serotype? (Nat Rev Micr)
- Adaptation of SARS-CoV-2 to mink/ferret (Cell Rep)
- Letters read on TWiV 871
- Timestamps by Jolene. Thanks!
Weekly Picks
Alan – Which Immune Cell Are You? and Michaeleen Doucleff's article
Rich – Vaccinated: One Man's Quest to Defeat the World's Deadliest Diseases by Paul A. Offit
Vincent – Ebola on Canvas
Listener Picks
Les – Ologies podcast
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology